Sepsis represents a dysregulated systemic inflammatory response to infection characterized by organ dysfunction from uncontrolled activation of innate immunity. The Sepsis-3 consensus definition (2016) defines sepsis as suspected or documented infection plus an acute increase in Sequential Organ Failure Assessment (SOFA) score of 2 or more points, reflecting a shift from homeostasis toward organ failure.

Understanding the molecular mechanisms underlying sepsis is critical for paramedics who encounter these patients in progressive stages of disease. The pathophysiology involves several interconnected processes initiated when bacterial lipopolysaccharides (LPS), peptidoglycans, and other pathogen-associated molecular patterns (PAMPs) bind to pattern recognition receptors (PRRs) on macrophages, dendritic cells, and endothelial cells.

Although identification of specific organism in the field is not possible; the patient history, recent diagnosis, medication regime or other factors may enable the paramedic to determine with reasonableness the scenario presenting. This combined with consultation with on-line medical control has the potential to make a meaningful difference in patient outcomes and mortality.

Molecular Cascade and Inflammatory Amplification

In gram-negative infections, immune cells, trigger a cytokine cascade. A term you may remember as being top of conversation during Covid and the concept of the “cytokine storm”. It is important to note that gram-positive organisms the inflammatory amplitude may differ from gram-negative pathogens. Tye released cytokines (tumor necrosis factor-alpha (TNF-alpha), interleukin-1-beta (IL-1B), and interleukin-6 (IL-6).] act on vascular endothelial cells, increasing vascular permeability. Simultaneously, the tissue factor (TF) pathway of coagulation becomes activated, triggering the extrinsic coagulation cascade (see also factors). This leads to thrombin generation, platelet activation, and microthrombi formation in the microvasculature. The protein C anticoagulant pathway becomes impaired in sepsis, setting the stage for disseminated intravascular coagulation (DIC) in severe cases.

Hemodynamic Consequences: From Compensation to Shock

The systemic release of inflammatory mediators causes widespread vasodilation and increased vascular permeability. In early sepsis, the body compensates through increased sympathetic tone, catecholamine release, and increased cardiac contractility. Heart rate increases to maintain cardiac output (CO = HR x stroke volume), and systemic vascular resistance (SVR) initially falls. Patients generally present in distributive shock, but it is important to note that while fundamentally septic shock, sepsis-induce myocardial dysfunction frequently coexists. Some patients develop a reduced ejection fraction and ventricular dysfunction that can produce a component of cardiac depression even while SCR remains low – so the two are not mutually exclusive, but the overall hemodynamic profile remains distributive. Measure and monitor mean arterial pressure (MAP), where despite elevated heart rate distributive shock will persist if untreated.

At the tissue level, mitochondrial dysfunction occurs from multiple mechanisms: reduced oxygen delivery (from decreased perfusion pressure and maldistribution of flow), increased oxygen consumption from inflammatory cells, and impaired mitochondrial oxidative phosphorylation from TNF-alpha and peroxynitrite. This results in anaerobic metabolism and lactate accumulation, which serves as both a marker of tissue hypoperfusion and a contributor to continued inflammation. This is why a lactate laboratory test provides correlating evidence of sepsis.

Sepsis-3 Definitions and Clinical Correlation

The Sepsis-3 framework replaced SIRS (Systemic Inflammatory Response Syndrome) criteria as the diagnostic standard because SIRS criteria lack specificity for sepsis; SIRS can occur with trauma, burns, pancreatitis, and other non-infectious processes. Sepsis-3 requires documentation or suspicion of infection PLUS organ dysfunction.

In the ICU, organ dysfunction is quantified by SOFA score, which includes Glasgow Coma Scale, oxygenation (PaO2/FiO2 ratio), mean arterial pressure, creatinine, bilirubin, and platelet count. A SOFA score increase of 2 or more from baseline indicates sepsis. Septic shock is defined as sepsis with refractory hypotension (systolic BP <90 mmHg or MAP <65 mmHg) requiring vasopressor support to maintain perfusion pressure AND elevated serum lactate (>2 mmol/L) despite fluid resuscitation.

For prehospital application, the qSOFA (quick SOFA) score provides a rapid risk stratification tool that identifies high-risk patients but lacks sensitivity for early sepsis. A qSOFA score of 2 or more includes:

• Altered mentation (Glasgow Coma Scale <15)
• Systolic blood pressure <100 mmHg
• Respiratory rate ≥ 22 breaths per minute

However, paramedics should recognize that patients with qSOFA score of 0-1 who show evidence of infection plus lactate elevation or other markers of organ dysfunction still require sepsis protocols.

Microbiology and Epidemiology of Sepsis

The source of infection dramatically influences pathophysiology and prognosis. Different organisms trigger distinct innate immune responses and have varying susceptibilities to antibiotics, making source identification critical. In the field a patient or family member may articulate the patient history and aide in identification of organism or primary colonization (urinary tract, pulmonary. intestinal…). In most cases the source is a working diagnosis in the field if new onset or an exacerbation of existing infection in most other scenarios

Respiratory Tract Infections

Community-acquired pneumonia (CAP) is the most common source of sepsis in the prehospital setting, accounting for approximately 30 to 40% of sepsis cases. Typical organisms include Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and atypical organisms such as Legionella and Mycoplasma in certain populations. Aspiration pneumonia may involve mixed aerobic and anaerobic flora from oropharyngeal flora.

Pneumonia-derived sepsis can progress rapidly, particularly in patients with underlying COPD, smoking history, or recent hospitalization. Severity correlates with bacterial load and host immune competence. The patient's chest imaging may not correlate with clinical severity; a patient with subtle radiographic findings can still be in septic shock.

Hospital acquired pneumonia and premature discharge remain potential scenarios and should not be discounted or eliminated in evaluation or documentation of the history of present illness ((HPI).

Urinary Tract Infections and Urosepsis

Urosepsis is often caused by gram-negative organisms (E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa) although Enterococcus and Staphylococcus species occur in catheterized patients. The combination of bacterial virulence factors (fimbriae for mucosal adherence, hemolysins, lipopolysaccharides) with obstructive uropathy or urinary stasis creates ideal conditions for ascending infection and bacteremia.

Elderly patients and those on immunosuppression frequently present with subtle urosepsis; confusion and hypotension may be the primary findings with minimal dysuria. Recent catheterization, intermittent catheterization, or retention from BPH significantly increases risk. Pregnant patients with asymptomatic bacteriuria have higher risk for progression to sepsis.

Abdominal and Intra-Abdominal Infections

Intra-abdominal sepsis accounts for roughly 20% of sepsis cases and often involves polymicrobial flora from bowel translocation. Bowel perforation, appendicitis, diverticulitis, mesenteric ischemia, and postoperative infections all create high-risk scenarios. Organisms include gram-negative aerobes (E. coli, Bacteroides fragilis) and anaerobes (Clostridium species, Peptostreptococcus) that produce beta-lactamase.

Abdominal sepsis frequently presents with shock that appears disproportionate to clinical findings. A patient may have only mild abdominal tenderness yet be in severe septic shock. This discordance occurs because the inflammatory stimulus is primarily intra-abdominal and systemic cytokine release has already occurred.

Skin and Soft Tissue Infections

Cellulitis, infected wounds, and abscesses can progress rapidly, particularly when caused by virulent organisms such as methicillin-resistant Staphylococcus aureus (MRSA) or Group A Streptococcus (Streptococcus pyogenes). The latter produces superantigen toxins (streptococcal pyrogenic exotoxins, SPE) that bypass normal MHC-TCR recognition, triggering massive T-cell activation and cytokine release. [See aseptic technique and phlebitis article for field tips.]

Immunocompromised patients (diabetes, HIV, cancer chemotherapy, immunosuppressive medications) are at increased risk for rapid progression from localized infection to sepsis. Diabetics in particular have impaired neutrophil function and altered cytokine responses, increasing susceptibility to both common and unusual organisms.

Other Sources

Meningitis from Neisseria meningitidis can rapidly progress to septic shock, often accompanied by meningococcal septicemia with petechial or purpuric rash. Endocarditis from viridans group streptococci, S. aureus (especially in IV drug users), or enterococci involves large inflammatory vegetations seeding septic emboli. Bone and joint infections (osteomyelitis, septic arthritis) from S. aureus or other organisms can seed bacteremia. Healthcare-associated infections in recently hospitalized patients may involve multidrug-resistant organisms and warrant empiric coverage for resistant pathogens.

Clinical Recognition: Presentation Across the Sepsis Spectrum

Sepsis manifests across a spectrum from early infection-induced inflammation to refractory septic shock with multi-organ failure. Paramedics typically encounter patients in various stages of progression, and recognition of subtle early findings dramatically improves outcomes.

Early Sepsis (No Organ Dysfunction or Minimal Findings)

• Fever or hypothermia (paradoxical hypothermia indicates worse prognosis and represents overwhelming immune dysregulation)
• Tachycardia in excess of what fever alone would explain (temperature increase of 1 degree C typically increases heart rate by 10-13 bpm)
• Tachypnea from compensation for metabolic acidosis and increased cellular demand
• Subtle altered mental status: inattention, drowsiness, or confusion that patient's family notes as "not themselves"
• Diaphoresis with cool extremities despite fever (reflects vasoconstriction and maldistribution)
• Lactate elevation (if measured via point-of-care testing): normal lactate is <2 mmol/L, and levels of 2-4 mmol/L indicate tissue hypoperfusion even with normal blood pressure
• Mild hyperglycemia in non-diabetics (stress hyperglycemia from catecholamine surge and impaired glucose metabolism)

Severe Sepsis (With Organ Dysfunction)

Severe sepsis develops when organ dysfunction becomes apparent. This includes:

• Hypotension (systolic BP <90 mmHg or MAP <65 mmHg) representing loss of sympathetic compensation
• Worsening altered mental status: confusion, disorientation, or decreased Glasgow Coma Scale
• Oliguria with acute kidney injury (decreased urinary output <0.5 mL/kg/hr; rising creatinine indicates failure of glomerular filtration)
• Respiratory compromise: increased work of breathing, hypoxemia despite supplemental oxygen, or evolving ARDS
• Elevated lactate (>4 mmol/L) indicating severe tissue hypoperfusion and anaerobic metabolism
• Coagulopathy: petechiae, purpura, or bleeding from DIC
• Mottled, cyanotic skin reflecting severe maldistribution of perfusion

Septic Shock (Refractory Hypotension with Tissue Hypoperfusion)

Septic shock represents the terminal stage prehospital providers often encounter. It is defined by refractory hypotension (not responding to adequate fluid resuscitation) requiring vasopressor support AND tissue hypoperfusion markers (elevated lactate, oliguria, altered mental status).

• Severe hypotension unresponsive to initial fluid boluses
• Profound altered mental status: patient may be unable to protect airway or provide history
• Severe tachycardia (often 120+ bpm) despite hypotension
• Severe tachypnea (often >30) with pulmonary edema from increased capillary permeability
• Cold extremities, mottled skin, slow capillary refill (>2 seconds) despite rapid heart rate
• Anuria or minimal urine output
• Lactate typically >4 mmol/L and often >10 mmol/L
• Signs of DIC: petechiae, purpura, oozing from IV sites or mucosal surfaces

Systematic Assessment for Sepsis Recognition

Paramedic assessment for sepsis requires integration of clinical presentation with knowledge of microbiology, hemodynamics, and inflammatory biology. Your assessment should construct a temporal and physiologic narrative of disease progression.

History: Infectious Source Identification

Systematic history should focus on identifying the likely source of infection and assessing baseline functional status versus acute change:

• Prodromal symptoms: onset and progression of fever, chills, malaise; timing may indicate stage of infection
• Localizing symptoms: cough with dyspnea (respiratory), dysuria and frequency (urinary), abdominal pain or diarrhea (GI), wound drainage or erythema (skin/soft tissue)
• Risk factors for rapid progression: diabetes (impaired immunity and endothelial dysfunction), recent surgery or hospitalization (healthcare-associated pathogens, impaired wound healing), IV drug use (bacteremia risk), immunosuppression (malignancy, HIV, medications), extremes of age
• Recent antibiotic exposure (influences organism selection and resistance patterns)
• Baseline cognitive status: family should confirm whether altered mental status is acute; chronic dementia complicates assessment but acute delirium in sepsis differs from baseline
• Baseline hemodynamics: is hypotension new or chronic? This influences fluid responsiveness and shock severity assessment

Vital Signs: Quantifying Physiologic Derangement

Vital signs provide objective quantification of systemic inflammation and organ dysfunction. These should be measured serially because trajectory matters more than single values:

• Temperature: Record actual core temperature. Both fever (>38.3 degrees C) and hypothermia (<36 degrees C) warrant concern. Hypothermia in suspected sepsis indicates severe disease with impaired thermoregulation and portends higher mortality.
• Heart rate: Tachycardia out of proportion to fever suggests systemic response. Compare observed HR to expected from fever alone. HR >110 in elderly or >130 in younger patient with only mild fever is concerning.
• Respiratory rate: CRITICAL ASSESSMENT. Tachypnea (RR ≥ 22) reflects compensation for metabolic acidosis. This is included in qSOFA for good reason. Count for full 60 seconds if possible; transient tachypnea may normalize, but sustained elevation indicates ongoing metabolic derangement.
• Blood pressure: Hypotension (SBP <90 mmHg or MAP <65 mmHg) indicates loss of compensatory mechanisms. MAP = (SBP + 2*DBP)/3. Calculate this if available; MAP <65 is critical threshold for organ perfusion.
• Oxygen saturation: SpO2 may be preserved in early sepsis but often declines as pulmonary capillary leak develops. Requirement for increasing FiO2 to maintain SpO2 suggests evolving pulmonary dysfunction.
• Lactate (if available via point-of-care device): Normal lactate <2 mmol/L. Lactate 2-4 mmol/L indicates tissue hypoperfusion and warrants aggressive resuscitation even if BP is normal. Lactate >4 mmol/L suggests severe hypoperfusion; lactate >10 mmol/L is associated with very high mortality.
• Urinary output: If patient is catheterized or you measure output, <0.5 mL/kg/hr indicates inadequate perfusion pressure to kidneys.

Physical Examination: Evidence of Infection and Shock

As always assure appropriate personal protective equipment (PPE) based upon presenting scenario. Today, especially in a post COVID environment, an appropriate mask, gown, gloves etc. is commonplace and should not be discounted. A focused examination should integrate assessment of perfusion with infection source identification as able. In each case noted positive clinical findings correlate to a potential “working diagnosis” which is helpful in overall care planning. Ultimately the physician will render the diagnosis, but this information will be informative and helpful.

• Skin and soft tissue: Inspect for cellulitis (erythema, warmth, induration), rash (particularly petechiae or purpura suggesting meningococcemia or endocarditis), infected wounds, or abscesses. Palpate for fluctuance. Assess skin temperature and capillary refill (normal <2 seconds; >2 seconds indicates poor perfusion). Mottled or cyanotic skin indicates severe maldistribution. Lungs: Auscultate for pneumonia (focal crackles, bronchial breath sounds, dullness to percussion). Sepsis-related acute respiratory distress syndrome (ARDS) may present with bilateral infiltrates and progressive hypoxemia despite increasing oxygen.
• Abdomen: Palpate systematically. Peritoneal signs (rebound tenderness, guarding) suggest peritonitis. Abdominal distension with tympany may indicate ileus. Note: absence of abdominal findings does NOT exclude intra-abdominal sepsis.
• Cardiovascular: Assess peripheral pulses for strength and presence. Bounding pulses with wide pulse pressure may indicate early sepsis with high cardiac output and low SVR. Weak pulses with narrow pulse pressure indicate advanced shock. Assess JVD; low JVD suggests hypovolemia, elevated JVD suggests right heart dysfunction or overload.
• Neurologic: Perform full Glasgow Coma Scale assessment. Document baseline pupil size and reactivity; some organisms (Neisseria meningitidis) cause meningitis with meningeal signs (neck stiffness, positive Kernig sign). Assess for focal neurologic deficits.
• Lymph nodes: Lymphadenopathy suggests systemic infection but is non-specific.

When to Activate Sepsis Protocol

Prehospital sepsis protocol activation should occur when: (1) documented or suspected infection (fever, localizing symptoms, immunocompromised state) PLUS systemic findings (tachycardia, tachypnea, altered mental status, hypotension, or elevated lactate); (2) qSOFA score ≥ 2; (3) any single organ dysfunction marker (SBP <90, RR ≥ 22, altered mental status) plus suspicion of infection; (4) elevated lactate (≥2 mmol/L) in context of possible infection.

Prehospital Management: Hemodynamic Support and Early Resuscitation

The goal of prehospital sepsis management is rapid restoration of tissue perfusion and prevention of progression to irreversible shock. Current evidence emphasizes aggressive early intervention; each hour of delay in appropriate resuscitation worsens outcomes.

Primary initial therapies include oxygenation and ventilation, being mindful to avoid hyperoxia. Target an SpO2 of 94%-98%. Higher oxygen saturations can increase free radicals and reduce outcomes. In septic shock with respiratory failure a higher target is appropriate. Position patient to optimize ventilation with the head of the bed 30-45 degrees.

Establish IV access immediately, with two large bore peripheral (bilateral) IV lines. Seek access at 18-guage or larger to reduce flow resistance and assure rapid administration. If IV access is not possible utlize intraosseous or seek external jugular access. In programs where allowed a central line should be considered. Early goal-directed therapy (EGDT) is the foundation of sepsis management. Initial fluid resuscitation: 30 mL/kg of crystalloid (normal saline or lactated Ringer) for hypotension OR signs of tissue hypoperfusion (elevated lactate, altered mental status, oliguria). Target restored perfusion pressure of MAP>=65 mmHg. Monitor closely for pulmonary edema; excessive crystalloids, particularly in elderly patients or those with concurrent heart failure or renal dysfunction, may worsen pulmonary edema. Balance perfusion pressure with pulmonary status.

Vasopressor Consideration

Vasopressors are typically initiated in the hospital after adequate fluid resuscitation. However, some advanced paramedic protocols may include prehospital vasopressor initiation for patients in refractory shock. Norepinephrine is the gold standard for sepsis titrated to maintain a MAP of >=65mmHg. Practical dosing is commonly cited therapeutic range of 0.01-0.5 μg/kg/min. In severe cases refractory to norepinephrine, an epinephrine drip should be considered under medical control.

Monitoring/Management/Transport

Continuous assessment during transport is necessary, but of course is the standard of care of all EMS and critical care transport. Assure: (1) serial vital signs: recheck every 5-10 minutes; (2) repeat lactate measurement (if available): lactate clearance of >10% indicates fluid responsiveness; persistent elevation suggests ongoing hypoperfusion or end-organ dysfunction; (3) continuously assess perfusion; (4) monitor mental status; (5) monitor urinary output if foley in place; (6) continuous ECG monitoring for arrythmias; (7) fluid balance. Patients with sepsis, particularly those with septic shock, benefit from rapid transport to hospitals with ICU capability and sepsis protocols.

Prioritize transport to facilities capable of managing septic shock: ICU availability, broad-spectrum antibiotic protocols, and capability for source control (drainage procedures, surgery). If your system has sepsis-receiving center designations, utilize them. Bypass closer facilities without appropriate capabilities and assure early notification.

Evidence Base: Outcomes Data and Clinical Trials

The evidence supporting aggressive prehospital sepsis management is robust and derived from landmark trials and multicenter implementation studies. The early goal-directed therapy (EGDT) trial by Rivers et al. (2001) demonstrated that early protocolized resuscitation in the emergency department reduced mortality from severe sepsis by 30%, from 46% to 30.5%. This study established the principle of early aggressive intervention within the first 6 hours of presentation.

More recent trials (ARISE, ProCESS, ProMISe) showed that the specific elements of EGDT (central venous pressure targets, ScvO2 monitoring) were less critical than the principle of rapid recognition and early fluid resuscitation. This supports the prehospital model: paramedic recognition and initiation of aggressive resuscitation is the critical intervention, not specific monitoring parameters.

Pitfalls, Mimics, and Management Challenges

Core temperature <36 degrees Celsius in suspected sepsis is actually a marker of severe disease, not reassurance. Hypothermia in sepsis reflects impaired thermoregulation from cytokine dysregulation and indicates worse prognosis than fever. Elderly patients, those on immunosuppressants (chemotherapy, biologics, corticosteroids), and those with severe malnutrition often present with hypothermia and sepsis. Do NOT be reassured by "normal" or low temperature; activate sepsis protocols based on other findings.

Another challenge can be that subtle early sepsis can present with only one qSOFA criterion while still representing life-threatening disease. A patient with pneumonia, fever, and mild tachypnea (RR 21) but normal blood pressure and normal mental status has qSOFA=1 yet may still require sepsis protocols. If lactate is elevated (even 2.5 mmol/L), tissue hypoperfusion exists and resuscitation is indicated. Use qSOFA as one tool, not the only trigger for sepsis protocols.

Differentiation from Other Causes of Shock

Septic shock can mimic other shock states, particularly when the infection source is not immediately obvious. Pulmonary embolism, acute myocardial infarction, hemorrhagic shock from occult bleeding, anaphylaxis, and cardiogenic shock from acute decompensation can all present with hypotension and altered mental status.

In cases of diagnostic uncertainty, ACTIVATE SEPSIS PROTOCOL. The harm from overtreatment of sepsis is minimal compared to the harm from missed diagnosis. On arrival, the emergency department physician can deactivate or change approach if needed. .

Conclusion

Sepsis remains one of the most time-sensitive medical emergencies encountered in the prehospital environment. What begins as a localized infection can rapidly progress to widespread inflammation, microvascular dysfunction, circulatory collapse, and multi-organ failure. Paramedics must prioritize early recognition and treatment ahead of definitive diagnosis. The setting, lack of laboratory and culture testing, and infectious disease training render a definitive diagnosis a task reserved for the emergency physician. Identifying the combination of suspected infection and emerging organ dysfunction allows treatment to begin during the critical early stages when intervention has the greatest impact on survival.

Paramedics hold a unique and expanding position in the chain of survival. Through careful history taking, assessment of vital-sign trends, identification of potential infection sources, and recognition of subtle indicators such as altered mental status, tachypnea, hypotension, or elevated lactate, providers can initiate lifesaving interventions before hospital arrival. Early oxygenation, appropriate fluid resuscitation, aggressive monitoring, rapid transport, and clear sepsis alerts to receiving facilities help shorten the time to definitive therapy and improve patient outcomes.

Perhaps the most important principle is that sepsis should be viewed as a dynamic process rather than a static diagnosis. Patients may deteriorate rapidly, and seemingly minor abnormalities can signal significant underlying physiologic derangement. When faced with uncertainty, providers should maintain a high index of suspicion and err on the side of early intervention. Recognition, reassessment, and timely action remain the cornerstones of successful prehospital sepsis care.

Visit my website: paramediclifeline.com for more information, tips and tools.

References

[1] Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. https://pubmed.ncbi.nlm.nih.gov/26903338/

[2] Seymour CW, Liu SX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762-774.

[3] Annals of Emergency Medicine. Sepsis-3 Definitions in the Prehospital Setting. https://www.annemergmed.com/article/S0196-0644(16)30377-8/fulltext

[4] Reinhart K, Deutschman CS, Seymour CW, et al. Immunopathophysiology of human sepsis. eBioMedicine. 2023;89:104501. https://pmc.ncbi.nlm.nih.gov/articles/PMC9783164/

[5] Rivers E, Nguyen B, Havstad S, et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock. N Engl J Med. 2001;345(19):1368-1377. https://www.nejm.org/doi/full/10.1056/NEJMoa010307

[6] Angus DC, Barnato AE, Bell D, et al. A systematic review and meta-analysis of early goal-directed therapy for sepsis: the ARISE, ProCESS, and ProMISe trials. Intensive Care Med. 2015;41(9):1549-1560. https://pmc.ncbi.nlm.nih.gov/articles/PMC6264603/

[7] De Backer D, Dorman T. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026;54(1):1-84. https://www.sccm.org/clinical-resources/guidelines/guidelines/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-septic-shock-2026

[8] JEMS. Assessing and Managing Sepsis in the Prehospital Setting. https://www.jems.com/patient-care/emergency-medical-care/assessing-managing-sepsis-in-the-prehospital-setting/

[9] Leet AS, Haydel J, Kallappa N, et al. Implementation of an EMS protocol to improve prehospital sepsis recognition. Prehosp Emerg Care. 2022;26(4):506-514. https://pubmed.ncbi.nlm.nih.gov/35500527/

[10] Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596.

[11] National Institutes of Health. Immunopathophysiology of Human Sepsis: Molecular Pathways and Therapeutic Avenues. PMC. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9783164/

[12] Cleveland Clinic. Sepsis: Symptoms, Causes, Treatment and Prevention. https://my.clevelandclinic.org/health/diseases/12361-sepsis

[13] Mayo Clinic. Sepsis: Symptoms and Causes. https://www.mayoclinic.org/diseases-conditions/sepsis/symptoms-causes/syc-20351214

[14] Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138-150.

[15] Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644-1655.